Ivermectin reduces motor coordination, serum testosterone, and central neurotransmitter levels but does not affect sexual motivation in male ratsN Moreira 1, T M Sandini 2, T M Reis-Silva 3, P Navas-Suáresz 4, A V V Auada 5, I Lebrun 5, J C Flório 6, M M Bernardi 7, H S Spinosa 6
- PMID: 29055807
- DOI: 10.1016/j.reprotox.2017.10.002
AbstractIvermectin (IVM) is a macrocyclic lactone used for the treatment of parasitic infections and widely used in veterinary medicine as endectocide. In mammals, evidence indicates that IVM interacts with γ-aminobutyric acid (GABA)-mediated chloride channels. GABAergic system is involved in the manifestation of sexual behavior. We previously found that IVM at therapeutic doses did not alter sexual behavior in male rats, but at a higher dose, the appetitive phase of sexual behavior was impaired. Thus, we investigated whether the reduction of sexual behavior that was previously observed was a consequence of motor or motivational deficits that are induced by IVM. Data showed significant decrease in striatal dopaminergic system activity and lower testosterone levels but no effects on sexual motivation or penile erection. These findings suggest IVM may activate the GABAergic system and reduce testosterone levels, resulting in a reduction of motor coordination as consequence of the inhibition of striatal dopamine release.
Keywords: Avermectin. GABA; Ivermectin; Neurotransmitters; Sexual behavior.